| HOME >> MEDICINE >> TECHNOLOGY |
CAMBRIDGE, England, October 6 /PRNewswire/ -- TCP Innovations, the Cambridge-based life sciences consultancy and seed investment fund, announced today the opening of its first office in the United States. The company has appointed Dr Robert W. Schroff as a Principal Consultant, who will lead a growing team of US consultants, closely integrated with the existing European group, to perform consulting projects for US clients. The US operation will be managed through the new office in Seattle, Washington.
Founded in 2001, TCP Innovations has grown into one of Europe's most successful life sciences consultancies, covering therapeutics, diagnostics, medical devices and healthcare technology. It has also been responsible for founding half a dozen new life sciences businesses, including the rapidly growing contract research organisation, Total Scientific, based on the Babraham science park and Funxional Therapeutics, a clinical-stage therapeutics company with exciting anti-inflammatory products in development, which has offices in central Cambridge.
David Grainger , a Principal Consultant at TCP Innovations said: "Opening an office in the United States, which represents the biggest market for our services, is an exciting step forward for our company. In an industry dominated by American companies, it is encouraging to see the UK exporting our talent in this area while remaining firmly based in Cambridge''.
As he joined the company, Bob Schroff said "The world-class scientific understanding and entrepreneurial experience that defines the TCP Innovations team is very much in demand in the US, and I look forward to delivering these services to the American market. Against a global backdrop of recession and economic gloom, it is pleasing to see a company expanding into new markets and going from strength to strength."
The expansion into the US also marks a new departure for the seed investment fund,
'/>"/>
| SOURCE TCP Innovations Ltd Copyright©2009 PR Newswire. All rights reserved |